. Recent developments, such as establishing harm reduction-oriented substitution treatment as an option to rehabilitation, has raised some concern about treatment becoming routine-like administration of medication without the psychosocial rehabilitation that constitutes the foundation for substance abuse treatment (Table 1 ). In addition, the general pressure to improve the cost-efficiency of substance abuse services has given rise to concern, as this is considered to lead to too limited treatment practices (Perälä, Hellman, Leppo, 2013) . However, knowledge of the actual developments of opioid substitution treatment is still fragmentary. Finally, we discuss the treatment systems from the point of view of discontinuation rates and mortality rates during treatment.
The comparison of treatment systems is flexibly based on the conceptual model of Babor, Stenius, and Romelsjö (2009) on treatment systems. In this model, characteristics of treatment systems (e.g. efficiency, fairness), treatment policies, structural Table 1 . Harm reduction and rehabilitation as treatment aims in opioid substitution treatment.
The Finnish decree on the treatment of opioid dependent persons (33/2008) defines substitution treatment in terms of its aims: "aim is either rehabilitation and abstinence or harm reduction and improvent in the patient´s quality of life". The usage of terms "rehabilitative substitution treatment" and "harm reduction" in the article ascend from this Finnish vocabulary, but they are also used to analyse treatment systems in other Nordic countries. This is justifiable, because the terms reflect two major approaches in international drug treatment policies: one emphasising abstinence as the ultimate treatment aim and the other improvements in the quality of life and the reduction of harms related to drug use.
resources (e.g., treatment methods) and patients' social and health status are considered to affect the treatment outcomes.
Our sources include mainly studies and reports on national drug abuse policies in Nordic countries; substitution treatment regulations and treatment guidelines; surveys and reports on substitution treatment;
and Nordic and international research literature relating to substitution treatment.
In addition, we asked the authorities in each country, or the institutes that are responsible for nationwide collection of data, to provide such information on substitution treatment that was not available from other sources. Thus, the article also provides new information. Data was collected in 2014. ). In addition, criticism on substitution treatment has become less intense and substitution treatment has become not only a part of normal discourse in Nordic substance abuse and opioid treatment services, but more and more frequently the key topic of general discussion on substance abuse treatment (Skretting & Rosenqvist, 2010) .
Substitution treatment in Nordic countries
The expansion and establishment of substitution treatment have followed different patterns in each country, which also reflects differences in treatment policies between the countries. Moreover, there are many differences related to treatment and treatment practices. Denmark has been providing opioid treatment since the 1960s, and the treatment practices are more customer-driven compared with the other Nordic countries (Thom, Duke, Assmussen & Bjarge, 2013; Asmussen, 2006) .
In March 2009, Denmark initiated heroin substitution treatment, which can be considered as a radical move in the Nordic context (Sundhedsstyrelsen, 2013a (Skretting & Rosenqvist, 2010) .
Swedish substitution treatment is like a mirror image of the Swedish drug policy, which takes a very strict approach to the drug problem and is based on the idea of total abstinence as the goal of treatment (Ekendahl, 2009 ). Finland and Norway both have what has been called a dual track policy (Tammi, 2007) , with strict drug policy but elements of harm reduction in drug treatment.
The Finnish and Norwegian substitution treatment policy can be placed in the middle ground between Sweden and Denmark. Finland initiated substitution treatment in the 1990s, which was relatively late. It was met with strong resistance at first, and similar to Sweden and Norway, the admission criteria were then strict. In the 2000s, however, Finland has considerably eased these criteria compared with Sweden. Harm reduction in addition to rehabilitative treatment is now emphasised more strongly (Skretting & Rosenqvist, 2010) .
What is common for all Nordic countries is the government's role as the financier and organiser of the treatment, as well as differences in opinions on substitution treatment between the social and health care sectors. In Finland and the other Nordic countries, the expansion of substitution treatment has led to critical discussion on the 'medicalisation' of treatment and the minor role of psycho-social care (Thom et al., 2013; Perälä et al., 2013) .
Coverage of substitution treatment, number of patients and patients' sociodemographic background in Nordic countries
The reliability of estimates of the number of problem opioid users 2 ( Table 2 ) varies between the Nordic countries. For example, only an estimate of the number of injecting drug users (13,000) is available from Denmark, but no estimate of the number of opioid problem users (Sundhedsstyrelsen, 2013b) . For Finland, there is an estimate available that is based on data from 2012, according to which Finland has 13,000-15,000 problem opioid users (Ollgren et al., 2014) . The Swedish Socialstyrelsen provides an exact figure (7,237), based on recorded opioid dependence diagnoses of clients of social and health care services and previous estimates on the number of abusers (Socialstyrelsen, 2012) . The reliability of the Swedish figure may be compromised for the reason that many problem drug users, in fear of stigmatisation, do not seek treatment at all or conceal their drug abuse when using social and health care services (EMCDDA, 2012a). In the Nordic countries, the estimated number of problem opioid users (particularly users of opiates, such as heroin) is thus highest in Finland, Denmark, and Norway and lowest in Sweden and Iceland. What is specific for Finland is that the most abused opioid is buprenorphine (Forsell & Nurmi, 2013) .
The number of patients in substitution treatment varies greatly ( Table 2 ). In Denmark, the number of patients has fallen from 7,850 in the peak year 2010 to 7,600 patients in 2011 (EMCDDA, 2013a) . It seems that Denmark is going in a different direction than the other Nordic countries, Unauthenticated Download Date | 12/16/16 1:10 PM , except the estimate of problem opioid users, which is from 2012 (Ollgren, 2014) . The coverage estimate is based on the ratio between the estimated number of problem opioid users and the number of substitution treatment patients. 2 Data for Sweden from 2012 (Socialstyrelsen, 2012) . The estimate of the number of patients is based on the number of diagnosed opiate dependence cases entered in the official registers. 3 Data for Norway from 2012 (Waal et al., 2013) , except the estimate of problem opioid users, which is from 2008 (EM-CDDA 2013c). The coverage estimate is based on the ratio between the estimated number of problem opioid users and the number of substitution treatment patients. 4 The data for Denmark from 2011 (number of patients) and 2006 (estimated number of injecting drug users) (Sundhedsstyrelsen, 2013b). There is no data on the exact number of opioid abusers, but it is estimated that most injecting drug users are opioid users (Sundhedsstyrelsen, 2013b) . (Forsell & Niemi, 2013 ). 2 Data for Sweden from 2012 (Socialstyrelsen, 2012) . 3 Data for Norway from 2012 (Waal et al., 2013) , except the education data, which was obtained from a follow-up study conducted in 1998-2009 (Lauritzen et al., 2012) . 4 Data for Denmark on patients who initiated treatment in 2010 -2014 (K. Frederiksen, personal communication, 21 February, 2014 . In addition, 20.8% of the patients belonged to category 'no education or education unknown'. Thus, the percentage of those with only basic education is probably higher than the figure in the table indicates.
number of prisoners in treatment is still very low EMCDDA, 2013c ).
The socio-demographic background of substitution treatment patients seems to be largely similar in all Nordic countries ( (Forsell & Nurmi, 2013) . Clearly over half of the patients in each country have completed only basic education or less. Employment rates are also very low.
Norway has the highest employment rate, 15% (24% in Central Norway) (Waal et al., 2013) . Homelessness is not very common.
In this context, 'homeless' refers to people who have been labelled as homeless in statistics. It is possible that the number of homeless is actually higher, either because of missing data or for reasons such as imprisonment or institutional care at the time of collecting data. In Sweden, the virtually zero homelessness rate is explained by the fact that you cannot be admitted to substitution treatment without a permanent address (Petersson, 2013) . In a Finnish 12-year follow-up study of clients of drug abuse services at the Helsinki Deaconess Institute, 27% (n=780) of patients who had sought treatment due to buprenorphine abuse were homeless (Uosukainen et al., 2013) . This figure is many times higher compared with nation-level data on clients of drug abuse services, according to which 4% of substitution treatment clients were homeless (Forsell & Nurmi, 2013) . It seems that in Finland, the percentage of homeless is lower among substitution treatment patients than among other patients who have sought treatment for opioid abuse.
Objectives and quality of substitution treatment in Nordic countries
According to the decree that entered into (Helsedirektoratet, 2010; Sundhedsstyrelsen, 2008; Socialstyrelsen, 2015) . However, local or regional guidelines are in place.
According to the data collected by the In Finland, the use of buprenorphine products as medication is more common than in the other Nordic countries, at the same time as abuse of buprenorphine products is the most common reason for seeking substitution treatment (Table 4 ).
In Denmark, the country with the most liberal drug policy, substitution treatment aims for the reduction of harmful effects Patients are admitted to treatment relatively quickly (within three to 12 weeks) (Waal et al., 2013) . Before the initiation of treatment, the patient must stop taking alcohol, benzodiazepines and hypnotics Then the patient may be given take-home doses if the doctor decides that this is suitable (Läkemedelsassisterad behandling, 2009 ). For the first six months, the patient must give three supervised urine samples per week (Petersson, 2013) . Treatment must be discontinued if the patient cannot promote the achievement of the goals. In addition, treatment may be discontinued if the patient skips treatment for more than a week, repeatedly takes drugs, uses alcohol in excess, manipulates urine samples, is convicted for a drug offence or an aggravated drug offence or repeatedly commits a minor drug offence during treatment (Läkemedelsassisterad behandling, 2009 ). The costs of substitution treatment in Sweden have been estimated at EUR 10,700 (SEK 100,000) per patient per year (Erikson, 2014) .
In Denmark and Iceland, there is no data available on the dosages of substitution treatment medication. In Finland, the average daily dose of methadone is 102 mg and the average daily dose of buprenorphine products is 16 mg (EMCDDA, 2011).
The doses are similar in Norway (Waal et al., 2013) . In Sweden, too, most patients receive similar doses as Finnish patients: 83% of methadone patients receive 60-120 mg per day, and 87% of patients taking buprenorphine products receive 8-24 mg per day (Socialstyrelsen, 2012) .
Unauthenticated
Download Date | 12/16/16 1:10 PM 
Deaths and discontinuations during treatment
There are many similarities and some in- (Socialstyrelsen, 2012) .
According to the EMCDDA's definition, the total number of drug-related deaths include deaths resulting from accidental or intentional poisoning and mental dis-orders due to drug use (Varjonen, Tanhua, & Forsell, 2014) . In Sweden, there were a total of 239 deaths due to these reasons in 2011 and 269 in 2010 (EMCDDA, 2012a .
The number of poisonings due to methadone has strongly increased in Sweden in recent years, but there are no clear signs of any connection between the increase and substitution treatment (Fugelstad, Johansson, & Thiblin, 2010 ). In Norway, the system has become more flexible as a result of the decree that entered into effect in 2010. Treatment aiming for harm reduction has been established in addition to rehabilitative treatment.
In Norway, where the overdose-induced mortality rate of heroin users has been very high even in international comparison (Simonsen et al., 2011) , there were 84 deaths of substitution treatment patients in 2012, with 54 cases the year before (Waal et al., 2013) . The total number of drug-related deaths in Norway was 248 in 2010 and 285 in 2009 (EMCDDA, 2012b).
The number of treatments discontinued involuntary has considerably decreased in Norway in recent years, from 250 cases in 2007 to 65 cases in the whole country in 2012 (Waal et al., 2013) . Adherence to treatment was also high in 2012: of patients who were in treatment at the beginning of the year or started treatment during the year, 92% were still in treatment at the end of the year, and 95% of patients had never discontinued their treatment (Waal et al., 2013) . The percentage of involuntary discontinuations of treatment by the treatment unit was low in Norway compared with Sweden, for example: 65 cases in 2012 (16% of discontinued treatments) and 39 cases in 2011 (8% of discontinued treatments) (Waal et al., 2013) .
There is no comprehensive data available on the deaths during treatment or the discontinuations of treatment from Finland. According to data collected from Espoo, Helsinki, Tampere, Turku and Vantaa 3 (Table 5) There is very little systematic data available on the backgrounds and circumstances of patients in treatment, even though such data would be important for the development of treatment. For example, a homeless substitution treatment patient is basically much worse off than a patient with a permanent home. Lack of housing or poor social resources also requires smooth co-operation between different authorities.
In our comparison, Sweden showed high mortality rates during substitution treatment. A number of contributing factors to this can be found: Compared with Finland, the patient group is different (mainly heroin users) and the number of drug-related deaths in general has been increasing for a long time. One reason may be the fact that substitution treatment is not allowed in involuntary treatment units. 
